Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Adrenergic Agonists: Direct-Acting Agents01:30

Adrenergic Agonists: Direct-Acting Agents

Drugs that mimic the action of endogenous catecholamines like noradrenaline and adrenaline are called adrenergic agonists or sympathomimetics. Based on their mechanism of action, sympathomimetics can be classified as direct-, indirect-, or mixed-acting sympathomimetics. Direct-acting adrenergic agonists activate adrenoceptors without affecting presynaptic neurons, making them independent of neuronal catecholamine-depleting agents like reserpine and guanethidine.
These agents can be classified...
Adrenergic Agonists: Therapeutic Classification01:18

Adrenergic Agonists: Therapeutic Classification

Adrenergic agonists can be classified based on their therapeutic uses and mechanisms of action. They serve various purposes in clinical applications.
Vasopressor or pressor agents: They increase blood pressure and function as cardiac stimulants. Examples include endogenous catecholamines (norepinephrine and dopamine) and synthetic agents (phenylephrine).
Bronchodilators: β2-agonists can relax bronchial muscles and widen airways. They are commonly used for treating obstructive pulmonary...
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of Prolonged Normobaric Hypoxia and Norepinephrine on the Rat Heart-Can They Be Reversed by Normoxic Recovery?

Cells·2026
Same author

Can Damage to the Rat Lung Induced by Prolonged Normobaric Hypoxia and Norepinephrine Be Reversed by Normoxic Recovery?

Current issues in molecular biology·2025
Same author

Artificial neural networks as a prognostic tool using hyperspectral imaging on pretherapeutic histopathological specimens of esophageal adenocarcinoma.

Journal of cancer research and clinical oncology·2025
Same author

Classification of esophageal cancer by using hyperspectral data.

International journal of computer assisted radiology and surgery·2025
Same author

Brain-breathing interaction during MRI-related anxiety.

Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology·2025
Same author

Patient-specific 3D-tissue slices from peritoneal metastases - An <i>in vitro</i> model for individual susceptibility analysis.

Pleura and peritoneum·2025

Related Experiment Video

Updated: May 16, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

Catecholamines can induce pulmonary remodeling in rats.

Beate Rassler1, Grit Marx, Katrin Schierle

  • 1Carl-Ludwig-Institute of Physiology, University of Leipzig, Leipzig, Germany. Beate.Rassler@medizin.uni-leipzig.de

Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology
|November 23, 2012
PubMed
Summary

Catecholamine infusion in rats causes pulmonary remodeling, with both alpha- and beta-adrenergic mechanisms contributing to extracellular matrix changes. Cardiac hypertrophy is primarily a beta-adrenergic effect.

More Related Videos

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

Related Experiment Videos

Last Updated: May 16, 2026

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats
07:29

The Left Pneumonectomy Combined with Monocrotaline or Sugen as a Model of Pulmonary Hypertension in Rats

Published on: March 8, 2019

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
07:13

A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure

Published on: April 30, 2020

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding
10:39

Rat Model of Right-Sided Cardiac Remodeling and Arrhythmia Using Pulmonary Artery Banding

Published on: August 30, 2024

Area of Science:

  • Pulmonary Medicine
  • Cardiovascular Research
  • Pharmacology

Background:

  • Catecholamine (CA) infusion in rats previously induced pulmonary injury, edema, and inflammation.
  • This study investigates CA effects on pulmonary extracellular matrix remodeling.

Purpose of the Study:

  • To examine the effects of norepinephrine (NE) and selective alpha- and beta-adrenergic agonists on pulmonary extracellular matrix remodeling.
  • To understand the mechanisms underlying catecholamine-induced lung injury and remodeling.

Main Methods:

  • Rats were infused with NE, phenylephrine (PE), isoproterenol (ISO), or saline for 8-72 hours.
  • Assessed mRNA expression of collagen, MMP-2, TIMP-2, and TGF-β isoforms in lung tissue.
  • Evaluated lung histology, hemodynamic function, and cardiac hypertrophy.

Main Results:

  • 72-hour infusion led to pulmonary fibrosis and vascular hypertrophy.
  • Elevated mRNA expression of collagen type I, MMP-2, and TIMP-2, most pronounced with NE.
  • TGF-β mRNA increased, particularly after PE; cardiac hypertrophy was most pronounced after ISO.

Conclusions:

  • Catecholamine infusion over 72 hours induces pulmonary remodeling via alpha- and beta-adrenergic mechanisms.
  • Cardiac hypertrophy is mainly mediated by beta-adrenergic stimulation, suggesting a direct adrenergic effect.
  • Pulmonary remodeling is distinct from, and not a direct consequence of, catecholamine-induced cardiac hypertrophy.